CXCL8 and asthma: In an early study, Simpson et al. showed that long-term clarithromycin therapy resulted in reductions in sputum IL-8 levels and neutrophil counts in patients with severe refractory asthma; however, no benefit in clinical outcomes such as lung function, dose response to hypertonic saline or asthma control scores was demonstrated [49].